Pasithea Therapeutics Announces Results from 2023 Annual
Disclosure related to the annual meeting of Pasithea Therapeutics (Nasdaq: KTTA)...
Source: globenewswire.com
Larry Steinman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Larry Steinman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Larry Steinman Today - Breaking & Trending Today
Trethera Receives NIH Grant for Preclinical Development in
LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs...
Source: globenewswire.com
Immunic, Inc. (NASDAQ:IMUX) Q4 2022 Earnings Call Transcript
Jessica Breu: Good morning and welcome to Immunic's Fourth Quarter and Year End 2022 Earnings Call. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic.
Source: insidermonkey.com
EQS-News: Immunic, Inc.: Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug's Neuroprotective Potential
Issuer: Immunic, Inc. / Key word(s): Study results/Conference Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting
Source: finanznachrichten.de
Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug's Neuroprotective Potential
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
Source: prnewswire.com